FDA Approved: ADAPALENE — Original Application (CALL INC. (dba Rochester Pharmaceuticals))

View source ↗

Summary

FDA approved a generic version of adapalene under ANDA 204593, allowing CALL INC. (dba Rochester Pharmaceuticals) to market adapalene for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Adapalene (Adapalene)

Snippet

ORIG AP for ADAPALENE (ADAPALENE)